Page 37 - Read Online

Xu et al. Cancer Drug Resist 2024;7:13 https://dx.doi.org/10.20517/cdr.2023.141 Page 13 of 14

a tissue-specific fashion. Cell Rep 2022;39:110740. DOI PubMed PMC
70. Luo P, Gong Y, Weng J, et al. CircKIF4A combines EIF4A3 to stabilize SDC1 expression to activate c-src/FAK and promotes TNBC
progression. Cell Signal 2023;108:110690. DOI PubMed
71. Gao H, Tuluhong D, Li X, et al. CircSNX25 mediated by SP1 promotes the carcinogenesis and development of triple-negative breast
cancer. Cell Signal 2023;109:110776. DOI PubMed
72. Turco C, Esposito G, Iaiza A, et al. MALAT1-dependent hsa_circ_0076611 regulates translation rate in triple-negative breast cancer.
Commun Biol 2022;5:598. DOI PubMed PMC
73. Song X, Chen B, Liang Y, et al. CircEIF3H-IGF2BP2-HuR scaffold complex promotes TNBC progression via stabilizing HSPD1/
RBM8A/G3BP1 mRNA. Cell Death Discov 2022;8:261. DOI PubMed PMC
74. Abe N, Matsumoto K, Nishihara M, et al. Rolling circle translation of circular RNA in living human cells. Sci Rep 2015;5:16435.
DOI PubMed PMC
75. Meyer K, Patil D, Zhou J, et al. 5′ UTR m6A Promotes cap-independent translation. Cell 2015;163:999-1010. DOI PubMed PMC
76. Song R, Guo P, Ren X, et al. A novel polypeptide CAPG-171aa encoded by circCAPG plays a critical role in triple-negative breast
cancer. Mol Cancer 2023;22:104. DOI PubMed PMC
77. Li Y, Wang Z, Su P, et al. circ-EIF6 encodes EIF6-224aa to promote TNBC progression via stabilizing MYH9 and activating the
Wnt/beta-catenin pathway. Mol Ther 2022;30:415-30. DOI PubMed PMC
78. Wang X, Jian W, Luo Q, Fang L. CircSEMA4B inhibits the progression of breast cancer by encoding a novel protein SEMA4B-
211aa and regulating AKT phosphorylation. Cell Death Dis 2022;13:794. DOI PubMed PMC
79. Li J, Ma M, Yang X, et al. Circular HER2 RNA positive triple negative breast cancer is sensitive to Pertuzumab. Mol Cancer
2020;19:142. DOI PubMed PMC
80. Hao R, Zhang L, Si Y, et al. A novel feedback regulated loop of circRRM2-IGF2BP1-MYC promotes breast cancer metastasis.
Cancer Cell Int 2023;23:54. DOI PubMed PMC
81. Ji C, Zhu L, Fang L. Hsa_circ_0000851 promotes PDK1/p-AKT-mediated cell proliferation and migration by regulating miR-1183 in
triple-negative breast cancer. Cell Signal 2023;101:110494. DOI PubMed
82. Liu P, Wang Z, Ou X, et al. The FUS/circEZH2/KLF5/ feedback loop contributes to CXCR4-induced liver metastasis of breast
cancer by enhancing epithelial-mesenchymal transition. Mol Cancer 2022;21:198. DOI PubMed PMC
83. Ju C, Zhou M, Du D, et al. EIF4A3-mediated circ_0042881 activates the RAS pathway via miR-217/SOS1 axis to facilitate breast
cancer progression. Cell Death Dis 2023;14:559. DOI PubMed PMC
84. Huang X, Tan W, Liu Z, et al. EIF4A3-induced circZFAND6 promotes breast cancer proliferation and metastasis through the miR-
647/FASN axis. Life Sci 2023;324:121745. DOI PubMed
85. Zheng W, Wang X, Yu Y, Ji C, Fang L. CircRNF10-DHX15 interaction suppressed breast cancer progression by antagonizing
DHX15-NF-κB p65 positive feedback loop. Cell Mol Biol Lett 2023;28:34. DOI PubMed PMC
86. Meng L, Chang S, Sang Y, et al. Circular RNA circCCDC85A inhibits breast cancer progression via acting as a miR-550a-5p sponge
to enhance MOB1A expression. Breast Cancer Res 2022;24:1. DOI PubMed PMC
87. Hanahan D, Weinberg R. Hallmarks of cancer: the next generation. Cell 2011;144:646-74. DOI PubMed
88. Safi A, Saberiyan M, Sanaei M, et al. The role of noncoding RNAs in metabolic reprogramming of cancer cells. Cell Mol Biol Lett
2023;28:37. DOI PubMed PMC
89. Cai Z, Hu Y, Liao K, Li H, Chen D, Ju H. Circular RNAs: emerging regulators of glucose metabolism in cancer. Cancer Lett
2023;552:215978. DOI PubMed
90. Ma W, Sun X, Zhang S, Chen Z, Yu J. Circ_0039960 regulates growth and Warburg effect of breast cancer cells via modulating miR-
1178/PRMT7 axis. Mol Cell Probes 2022;64:101829. DOI PubMed
91. Dou D, Ren X, Han M, et al. Circ_0008039 supports breast cancer cell proliferation, migration, invasion, and glycolysis by regulating
the miR-140-3p/SKA2 axis. Mol Oncol 2021;15:697-709. DOI PubMed PMC
92. Cao L, Wang M, Dong Y, et al. Circular RNA circRNF20 promotes breast cancer tumorigenesis and Warburg effect through miR-
487a/HIF-1α/HK2. Cell Death Dis 2020;11:145. DOI PubMed PMC
93. Tian J, Liu S, Yu C, Wu L, Wang L. The role of non-coding RNAs in breast cancer drug resistance. Front Oncol 2021;11:702082.
DOI PubMed PMC
94. Tang AH, Hoefer RA, Guye ML, Bear HD. Persistent EGFR/K-RAS/SIAH pathway activation drives chemo-resistance and early
tumor relapse in triple-negative breast cancer. Cancer Drug Resist 2022;5:691-702. DOI PubMed PMC
95. Xia M, Zu X, Chen Z, Wen G, Zhong J. Noncoding RNAs in triple negative breast cancer: mechanisms for chemoresistance. Cancer
Lett 2021;523:100-10. DOI PubMed
96. Misir S, Ozer Yaman S, Petrović N, Sumer C, Hepokur C, Aliyazicioglu Y. circRNAs in drug resistance of breast cancer. Oncol Res
2022;30:157-72. DOI PubMed PMC
97. Wang X, Chen T, Li C, et al. CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by
destabilizing PKR. J Hematol Oncol 2022;15:122. DOI PubMed PMC
98. Wang X, Yao Y, Jin M. Circ-0001068 is a novel biomarker for ovarian cancer and inducer of PD1 expression in T cells. Aging
2020;12:19095-106. DOI PubMed PMC
99. Wang J, Zhao X, Wang Y, et al. circRNA-002178 act as a ceRNA to promote PDL1/PD1 expression in lung adenocarcinoma. Cell
Death Dis 2020;11:32. DOI PubMed PMC